TechnoMark News

The significant growth of the market can be attributed to growing number of geriatric population followed by increasing number of cancer patients. Moreover, technological advancements in ablation devices in emerging countries, is anticipated to boost the growth of the tumor ablation market over the forecast period. However, high cost of tumor ablation treatment is likely to restrain the market to a certain extent. Major Key Players of the Tumor Ablation Market are: Medtronic, Integra LifeSciences Corporation, AngioDynamics, Boston Scientific Corporation, NeuWave Medical, (Johnson & Johnson Services), Galil Medical Inc. (BTG International Ltd), Misonix, HealthTronics, Inc., Sonacare Medical, MERMAID MEDICAL A/S among others. Read More @  https://www.medgadget.com/2020/10/tumor-ablation-market-size-competitive-strategies-application-analysis-regional-and-forecasts-2019-to-2030.html According to World Health Organization, around 13% of the populace worldwide is aged 65 and above. ...

Tumor Ablation is estimated to be over US$ 545.3 Mn in 2018. It is anticipated to grow at 11.1% CAGR from 2019 to 2030. The significant growth of the market can be attributed to growing number of geriatric population followed by increasing number of cancer patients. Moreover, technological advancements in ablation devices in emerging countries, is anticipated to boost the growth of the tumor ablation market over the forecast period. However, high cost of tumor ablation treatment is likely to restrain the market to a certain extent. Major Key Players of the Tumor Ablation Market are: Medtronic, Integra LifeSciences Corporation, AngioDynamics, Boston Scientific Corporation, NeuWave Medical, (Johnson & Johnson Services), Galil Medical Inc. (BTG International Ltd), Misonix, HealthTronics, Inc., Sonacare Medical, MERMAID MEDICAL A/S among others. Read More @  https://www.medgadget.com/2020/10/tumor-ablation-market-size-competitive-strategies-application-analysis-regional-and-forecas...

Tumor Ablation is estimated to be over US$ 545.3 Mn in 2018. It is anticipated to grow at 11.1% CAGR from 2019 to 2030. The significant growth of the market can be attributed to growing number of geriatric population followed by increasing number of cancer patients. Moreover, technological advancements in ablation devices in emerging countries, is anticipated to boost the growth of the tumor ablation market over the forecast period. However, high cost of tumor ablation treatment is likely to restrain the market to a certain extent. Major Key Players of the Tumor Ablation Market are: Medtronic, Integra LifeSciences Corporation, AngioDynamics, Boston Scientific Corporation, NeuWave Medical, (Johnson & Johnson Services), Galil Medical Inc. (BTG International Ltd), Misonix, HealthTronics, Inc., Sonacare Medical, MERMAID MEDICAL A/S among others. Read More @  https://www.medgadget.com/2020/10/tumor-ablation-market-size-competitive-strategies-application-analysis-regional-and-forecas...

Tumor ablation is referred to as a minimally invasive technique that is commonly used in the treatment of tumors of the liver, kidney, bone, and lung among others. It can be used as a first-line treatment or in cases of failed chemotherapy or radiotherapy or for any non-surgical candidates.  Tumor Ablation  systems in general comprise a generator and a needlelike device that delivers the energy directly to the targeted tissue to cause acute cellular necrosis. Major Key Players of the Tumor Ablation Market are: Medtronic, Integra LifeSciences Corporation, AngioDynamics, Boston Scientific Corporation, NeuWave Medical, (Johnson & Johnson Services), Galil Medical Inc. (BTG International Ltd), Misonix, HealthTronics, Inc., Sonacare Medical, MERMAID MEDICAL A/S among others. Read More @  http://www.sbwire.com/press-releases/tumor-ablation-market-2019-past-analysis-and-future-forecast-to-2030-medtronic-integra-lifesciences-1297452.htm  

Tumor ablation is referred to as a minimally invasive technique that is commonly used in the treatment of tumors of the liver, kidney, bone, and lung among others. It can be used as a first-line treatment or in cases of failed chemotherapy or radiotherapy or for any non-surgical candidates. Ablation systems in general comprise of a generator and a needlelike device that delivers the energy directly to the targeted tissue to cause acute cellular necrosis. The tumor ablation market is witnessing growth due to factors such as growing geriatric population and increasing cancer population. Moreover, technological advancement in ablation devices will further fuel the growth of tumor ablation over the forecast period. However, high cost of tumor ablation treatment is likely to restrain the market to a certain extent. According to the report, the global tumor Ablation is estimated to be over US$ 545.3 Mn in 2018. It is anticipated to grow at 11.1% CAGR from 2019 to 2030. Major Key Players of t...

Tumor ablation market was estimated to be over US$ 545.3 Million in 2018. It is anticipated to grow at a CAGR of 11.1% from 2019 to 2030. The growth of market can be attributed to several factors, such as growing geriatric population and increasing cancer population, which has led to its wide-scale adoption. As per, Population Projections 2017-2060 by US Census Bureau, the number of adults, aged 85yrs and above are expected to nearly triple from 6.4 million in 2016 to 19.0 million by 2060. According to a recent study by American Cancer Society, cancer usually develops in older people and 80% of all cancers in the United States are diagnosed in people of 55 years or older. The rapidly growing older population will increase demand for cancer care, which will in turn have a substantial impact on growth of tumor ablation market. Major Key Players of the Tumor Ablation Market are: Medtronic, Integra LifeSciences Corporation, AngioDynamics, Boston Scientific Corporation, NeuWave Medical,...